PF-06826647
TYK2-selective kinase inhibitor (JH1 domain) in Ph. II for inflamm. conditions (oral, QD) from structure-based design J. Med. Chem., Aug. 5, 2020 Pfizer, Cambridge, MA / Groton, CT
Molecules of the Month - August 2020
Molecules of the Month
- GS-6207
- PF-06826647
- MSA-2
- SR-717
- Vixotrigine (BIIB074)
- BI-3406
- "compound 3d"
- "compound 12" (GlaxoSmithKline)
- "compound 12j"
- "compound 7f"
- DS34942424
- "compound 12"
- "compound 37"
- "compound 20"